92
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      The Safety of Ingested Caffeine: A Comprehensive Review

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Caffeine is the most widely consumed psychoactive drug in the world. Natural sources of caffeine include coffee, tea, and chocolate. Synthetic caffeine is also added to products to promote arousal, alertness, energy, and elevated mood. Over the past decade, the introduction of new caffeine-containing food products, as well as changes in consumption patterns of the more traditional sources of caffeine, has increased scrutiny by health authorities and regulatory bodies about the overall consumption of caffeine and its potential cumulative effects on behavior and physiology. Of particular concern is the rate of caffeine intake among populations potentially vulnerable to the negative effects of caffeine consumption: pregnant and lactating women, children and adolescents, young adults, and people with underlying heart or other health conditions, such as mental illness. Here, we review the research into the safety and safe doses of ingested caffeine in healthy and in vulnerable populations. We report that, for healthy adults, caffeine consumption is relatively safe, but that for some vulnerable populations, caffeine consumption could be harmful, including impairments in cardiovascular function, sleep, and substance use. We also identified several gaps in the literature on which we based recommendations for the future of caffeine research.

          Related collections

          Most cited references246

          • Record: found
          • Abstract: found
          • Article: not found

          Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Aging.

          J. Lindsay (2002)
          A prospective analysis of risk factors for Alzheimer's disease was a major objective of the Canadian Study of Health and Aging, a nationwide, population-based study. Of 6,434 eligible subjects aged 65 years or older in 1991, 4,615 were alive in 1996 and participated in the follow-up study. All participants were cognitively normal in 1991 when they completed a risk factor questionnaire. Their cognitive status was reassessed 5 years later by using a similar two-phase procedure, including a screening interview, followed by a clinical examination when indicated. The analysis included 194 Alzheimer's disease cases and 3,894 cognitively normal controls. Increasing age, fewer years of education, and the apolipoprotein E epsilon4 allele were significantly associated with increased risk of Alzheimer's disease. Use of nonsteroidal anti-inflammatory drugs, wine consumption, coffee consumption, and regular physical activity were associated with a reduced risk of Alzheimer's disease. No statistically significant association was found for family history of dementia, sex, history of depression, estrogen replacement therapy, head trauma, antiperspirant or antacid use, smoking, high blood pressure, heart disease, or stroke. The protective associations warrant further study. In particular, regular physical activity could be an important component of a preventive strategy against Alzheimer's disease and many other conditions.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found
            Is Open Access

            A review of caffeine's effects on cognitive, physical and occupational performance.

            Caffeine is consumed by over 80% of U.S. adults. This review examines the effects caffeine has on cognitive and physical function, since most real-world activities require complex decision making, motor processing and movement. Caffeine exerts its effects by blocking adenosine receptors. Following low (∼40mg or ∼0.5mgkg(-1)) to moderate (∼300mg or 4mgkg(-1)) caffeine doses, alertness, vigilance, attention, reaction time and attention improve, but less consistent effects are observed on memory and higher-order executive function, such as judgment and decision making. Effects on physical performance on a vast array of physical performance metrics such as time-to-exhaustion, time-trial, muscle strength and endurance, and high-intensity sprints typical of team sports are evident following doses that exceed about 200mg (∼3mgkg(-1)). Many occupations, including military, first responders, transport workers and factory shift workers, require optimal physical and cognitive function to ensure success, workplace safety and productivity. In these circumstances, that may include restricted sleep, repeated administration of caffeine is an effective strategy to maintain physical and cognitive capabilities.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Health effects of energy drinks on children, adolescents, and young adults.

              To review the effects, adverse consequences, and extent of energy drink consumption among children, adolescents, and young adults. We searched PubMed and Google using "energy drink," "sports drink," "guarana," "caffeine," "taurine," "ADHD," "diabetes," "children," "adolescents," "insulin," "eating disorders," and "poison control center" to identify articles related to energy drinks. Manufacturer Web sites were reviewed for product information. According to self-report surveys, energy drinks are consumed by 30% to 50% of adolescents and young adults. Frequently containing high and unregulated amounts of caffeine, these drinks have been reported in association with serious adverse effects, especially in children, adolescents, and young adults with seizures, diabetes, cardiac abnormalities, or mood and behavioral disorders or those who take certain medications. Of the 5448 US caffeine overdoses reported in 2007, 46% occurred in those younger than 19 years. Several countries and states have debated or restricted energy drink sales and advertising. Energy drinks have no therapeutic benefit, and many ingredients are understudied and not regulated. The known and unknown pharmacology of agents included in such drinks, combined with reports of toxicity, raises concern for potentially serious adverse effects in association with energy drink use. In the short-term, pediatricians need to be aware of the possible effects of energy drinks in vulnerable populations and screen for consumption to educate families. Long-term research should aim to understand the effects in at-risk populations. Toxicity surveillance should be improved, and regulations of energy drink sales and consumption should be based on appropriate research.
                Bookmark

                Author and article information

                Contributors
                URI : http://frontiersin.org/people/u/410843
                URI : http://frontiersin.org/people/u/55359
                URI : http://frontiersin.org/people/u/69544
                URI : http://frontiersin.org/people/u/411220
                Journal
                Front Psychiatry
                Front Psychiatry
                Front. Psychiatry
                Frontiers in Psychiatry
                Frontiers Media S.A.
                1664-0640
                26 May 2017
                2017
                : 8
                : 80
                Affiliations
                [1] 1Department of Exercise and Nutrition Sciences, University at Buffalo , Buffalo, NY, USA
                [2] 2Department of Community Health and Health Behavior, University at Buffalo , Buffalo, NY, USA
                [3] 3Aix Marseille Univ, INSERM, INS, Inst Neurosci Syst , Marseille, France
                [4] 4Wayne State University School of Medicine, Children’s Hospital of Michigan , Detroit, MI, USA
                Author notes

                Edited by: Jeffrey Witkin, Lilly Research Labs, USA

                Reviewed by: Mary Margaret Sweeney, Johns Hopkins School of Medicine, USA; Shobhit Jain, Banaras Hindu University, India

                *Correspondence: Jennifer L. Temple, jltemple@ 123456buffalo.edu

                These authors have contributed equally to this work.

                Specialty section: This article was submitted to Psychopharmacology, a section of the journal Frontiers in Psychiatry

                Article
                10.3389/fpsyt.2017.00080
                5445139
                28603504
                53ba9951-d6bd-4fd4-b315-c5e263ff46c9
                Copyright © 2017 Temple, Bernard, Lipshultz, Czachor, Westphal and Mestre.

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 30 January 2017
                : 24 April 2017
                Page count
                Figures: 0, Tables: 1, Equations: 0, References: 258, Pages: 19, Words: 18544
                Funding
                Funded by: National Institute on Drug Abuse 10.13039/100000026
                Award ID: DA021759, DA030386
                Funded by: National Institute of Diabetes and Digestive and Kidney Diseases 10.13039/100000062
                Award ID: DK106265
                Funded by: National Heart, Lung, and Blood Institute 10.13039/100000050
                Award ID: HL111459, HL109090, HL078522, HL053392, HL079233, HL087000, HL060325
                Funded by: National Institute of Nursing Research 10.13039/100000056
                Award ID: NR012885
                Funded by: National Cancer Institute 10.13039/100000054
                Award ID: CA127642, CA068484
                Funded by: National Institute of Child Health and Human Development 10.13039/100000071
                Award ID: HD052104
                Categories
                Psychiatry
                Review

                Clinical Psychology & Psychiatry
                caffeine,energy drinks,pregnancy,children,adolescence
                Clinical Psychology & Psychiatry
                caffeine, energy drinks, pregnancy, children, adolescence

                Comments

                Comment on this article